Insider Transactions in Q1 2022 at Ikena Oncology, Inc. (IKNA)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 18
2022
|
Maude Tessier Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
71,786
+21.71%
|
$215,358
$3.87 P/Share
|
|
Jan 11
2022
|
Xiaoyan Michelle Zhang Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
964
-2.12%
|
$11,568
$12.0 P/Share
|
|
Jan 11
2022
|
Xiaoyan Michelle Zhang Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
964
+2.08%
|
$1,928
$2.15 P/Share
|
|
Jan 10
2022
|
Xiaoyan Michelle Zhang Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
36
-0.08%
|
$432
$12.0 P/Share
|
|
Jan 10
2022
|
Xiaoyan Michelle Zhang Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
36
+0.08%
|
$72
$2.15 P/Share
|